Last updated on November 2015

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder


Brief description of study

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder

Detailed Study Description

The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.

Clinical Study Identifier: TX141996

Contact Investigators or Research Sites near you

Start Over

Alexis Wolfe

University of South Florida- Rothman Center for Pediatric Neuropsychiatry
St. Petersburg, FL USA
  Connect »